Page last updated: 2024-10-31

metoclopramide and Pituitary Diseases

metoclopramide has been researched along with Pituitary Diseases in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Pituitary Diseases: Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishida, S1
Matsuki, M1
Horino, M1
Kawai, Y1
Tsushima, K1
Yoneda, M1
Oyama, H1
Ishii, R1

Other Studies

1 other study available for metoclopramide and Pituitary Diseases

ArticleYear
Dopamine-mediated effects induced by metoclopramide simultaneously on adrenocorticotropic hormone and prolactin in patients with pituitary and/or hypothalamic disorders.
    Clinica chimica acta; international journal of clinical chemistry, 1990, Oct-15, Volume: 190, Issue:3

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Child; Dopamine; Female; Growth Hormone; Human

1990